title: BRIGHT HORIZONS for Bivalirudin? EUROMAXimizing benefits of bleeding risk but catching a MATRIX of HEAT for stent thrombosis.
authors: Center for Interventional Vascular Therapy, Division of Cardiology, New York Presbyterian Hospital and Columbia University, New York, NY, USA.
authors: Jonathan
authors: J
authors: Soverow
authors: Center for Interventional Vascular Therapy, Division of Cardiology, New York Presbyterian Hospital and Columbia University, New York, NY, USA; Cardiovascular Research Foundation, New York, NY, USA.
authors: Ziad
authors: Z
authors: Ali
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D000991:Antithrombins / Q000627:therapeutic use; D006470:Hemorrhage; D006493:Heparin / Q000627:therapeutic use; D006358:Hot Temperature; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy; D062645:Percutaneous Coronary Intervention; D011994:Recombinant Proteins; D015607:Stents; D013927:Thrombosis / Q000188:drug therapy; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D000991:Antithrombins; D011994:Recombinant Proteins; D006493:Heparin